We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




R&D Systems to Develop Cytokine Assays for Beckman

By HospiMedica staff writers
Posted on 22 Oct 2003
A nonexclusive, multi-year agreement has been announced by Beckman Coulter (Fullerton, CA, USA) and R&D Systems (Minneapolis, MN, USA) under which R&D Systems will develop automated cytokine assays and manufacture assay components designed for Beckman's Access family of immunoassay systems.

R&D Systems will develop and manufacture immunoassays based on Beckman Coulter's magnetic particle, chemiluminescent immunoassay technology. More...
The initial focus of the agreement will serve to expand Beckman's leadership position in anemia testing to include erythropoietin, a principal cytokine factor regulating red blood cell production, and soluble transferring receptor (STFR), considered the best indicator of iron deficiency.

Beckman Coulter currently offers a wide array of tests for the diagnosis and monitoring of anemia that are run on its hematology analyzers. The addition of new assays for biologics and cytokines will enhance the company's portfolio of products.

"Because we maintain a best-of-breed philosophy around our assay design, development, and manufacture, R&D Systems was clearly an excellent partner,” said Michael Whelan, vice president, immunoassay and nucleic acid testing, for Beckman Coulter. "Their expertise will be instrumental in our efforts to strengthen our position in the automated immunoassay market.”





Related Links:
Beckman Coulter
R&D Systems

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Automated Urinalysis Solution
UN-9000
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Adobe Stock

Blood Biomarkers Help Assess Growth Risks During Steroid Treatment in Duchenne Muscular Dystrophy

Children with Duchenne muscular dystrophy (DMD) commonly receive long-term corticosteroids to slow disease progression, but these drugs can impair linear growth and weaken bone. Understanding how specific... Read more

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.